Invivyd Inc.

01/10/2025 | Press release | Distributed by Public on 01/10/2025 06:01

Invivyd Announces Continued Neutralizing Activity of PEMGARDA™ (pemivibart) Against Dominant SARS-CoV-2 Variant XEC